Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Lam

Showing results (141-150 of 843) with videos related to

Pageof 85
Sort By:
Diabetes, Obesity & Metabolism|September 19, 2018
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized Desiree Abdurrachim, Xing Qi Teo, Chern Chiuh Woo, et al.
Journal of Cardiac Failure|April 23, 2026
Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific StatementJane E Wilcox, Lars H Lund, Zachary L Cox, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2010
Size, shape, and stamina: the impact of left ventricular geometry on exercise capacityCarolyn S P Lam, Jasmine Grewal, Barry A Borlaug, et al.
Circulation. Heart Failure|May 28, 2019
Understanding Contemporary Use of ThiazolidinedionesSuzanne V Arnold, Silvio E Inzucchi, Justin B Echouffo-Tcheugui, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 22, 2022
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?Kieran F Docherty, Antoni Bayes-Genis, Javed Butler, et al.
European Journal of Heart Failure|June 8, 2018
Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fractionJan F Nauta, Yoran M Hummel, Peter van der Meer, et al.
Journal of Cardiac Failure|September 19, 2022
Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection FractionKhawaja M Talha, Stefan D Anker, Daniel Burkhoff, et al.
Heart (British Cardiac Society)|May 17, 2019
The diabetes-atrial fibrillation paradoxEugene S J Tan, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Diabetes, Obesity & Metabolism|February 8, 2024
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and managementJiten Vora, David Cherney, Mikhail N Kosiborod, et al.
Nature Reviews. Disease Primers|August 25, 2017
Heart failure with reduced ejection fractionMichelle W Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Pageof 85

Showing results (141-150 of 843) with videos related to

Sort By:
Pageof 85
Diabetes, Obesity & Metabolism|September 19, 2018
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized Desiree Abdurrachim, Xing Qi Teo, Chern Chiuh Woo, et al.
Journal of Cardiac Failure|April 23, 2026
Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific StatementJane E Wilcox, Lars H Lund, Zachary L Cox, et al.
Hypertension (Dallas, Tex. : 1979)|March 11, 2010
Size, shape, and stamina: the impact of left ventricular geometry on exercise capacityCarolyn S P Lam, Jasmine Grewal, Barry A Borlaug, et al.
Circulation. Heart Failure|May 28, 2019
Understanding Contemporary Use of ThiazolidinedionesSuzanne V Arnold, Silvio E Inzucchi, Justin B Echouffo-Tcheugui, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|December 22, 2022
The four pillars of HFrEF therapy: is it time to treat heart failure regardless of ejection fraction?Kieran F Docherty, Antoni Bayes-Genis, Javed Butler, et al.
European Journal of Heart Failure|June 8, 2018
Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fractionJan F Nauta, Yoran M Hummel, Peter van der Meer, et al.
Journal of Cardiac Failure|September 19, 2022
Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection FractionKhawaja M Talha, Stefan D Anker, Daniel Burkhoff, et al.
Heart (British Cardiac Society)|May 17, 2019
The diabetes-atrial fibrillation paradoxEugene S J Tan, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Diabetes, Obesity & Metabolism|February 8, 2024
Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and managementJiten Vora, David Cherney, Mikhail N Kosiborod, et al.
Nature Reviews. Disease Primers|August 25, 2017
Heart failure with reduced ejection fractionMichelle W Bloom, Barry Greenberg, Tiny Jaarsma, et al.
Pageof 85